EMA starts review of Tavneos, a medicine for rare autoimmune diseases GPA and MPA

View source ↗

Summary

The EMA has started a review of Tavneos (avacopan) after questions were raised about the integrity of data from the main pivotal study in granulomatosis with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• TAVNEOS (avacopan)

Snippet

Review prompted by questions regarding data integrity of main study